228 related articles for article (PubMed ID: 18667590)
1. Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model.
Morey Kinney SR; Smiraglia DJ; James SR; Moser MT; Foster BA; Karpf AR
Mol Cancer Res; 2008 Aug; 6(8):1365-74. PubMed ID: 18667590
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation pathway alterations in an autochthonous murine model of prostate cancer.
Morey SR; Smiraglia DJ; James SR; Yu J; Moser MT; Foster BA; Karpf AR
Cancer Res; 2006 Dec; 66(24):11659-67. PubMed ID: 17178860
[TBL] [Abstract][Full Text] [Related]
3. Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer.
Kinney SR; Moser MT; Pascual M; Greally JM; Foster BA; Karpf AR
Mol Cell Biol; 2010 Sep; 30(17):4159-74. PubMed ID: 20584988
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
6. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
8. Role of the cytosine DNA-methyltransferase and p16INK4a genes in the development of mouse lung tumors.
Belinsky SA
Exp Lung Res; 1998; 24(4):463-79. PubMed ID: 9659578
[TBL] [Abstract][Full Text] [Related]
9. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.
Mavis CK; Morey Kinney SR; Foster BA; Karpf AR
Prostate; 2009 Sep; 69(12):1312-24. PubMed ID: 19444856
[TBL] [Abstract][Full Text] [Related]
10. DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.
Zhu A; Hopkins KM; Friedman RA; Bernstock JD; Broustas CG; Lieberman HB
Carcinogenesis; 2021 Feb; 42(2):220-231. PubMed ID: 32780107
[TBL] [Abstract][Full Text] [Related]
11. A γ-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation.
Huang Y; Khor TO; Shu L; Saw CL; Wu TY; Suh N; Yang CS; Kong AN
J Nutr; 2012 May; 142(5):818-23. PubMed ID: 22457388
[TBL] [Abstract][Full Text] [Related]
12. Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm.
Cho NY; Kim JH; Moon KC; Kang GH
Virchows Arch; 2009 Jan; 454(1):17-23. PubMed ID: 19048291
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase and demethylase in human prostate cancer.
Patra SK; Patra A; Zhao H; Dahiya R
Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate.
Morey Kinney SR; Zhang W; Pascual M; Greally JM; Gillard BM; Karasik E; Foster BA; Karpf AR
Cancer Prev Res (Phila); 2009 Dec; 2(12):1065-75. PubMed ID: 19934341
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer.
McCabe MT; Low JA; Daignault S; Imperiale MJ; Wojno KJ; Day ML
Cancer Res; 2006 Jan; 66(1):385-92. PubMed ID: 16397253
[TBL] [Abstract][Full Text] [Related]
16. Phenotype-specific CpG island methylation events in a murine model of prostate cancer.
Camoriano M; Kinney SR; Moser MT; Foster BA; Mohler JL; Trump DL; Karpf AR; Smiraglia DJ
Cancer Res; 2008 Jun; 68(11):4173-82. PubMed ID: 18519676
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
18. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
[TBL] [Abstract][Full Text] [Related]
19. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
Jain AK; Raina K; Agarwal R
Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
Lotan TL; Lyon M; Huo D; Taxy JB; Brendler C; Foster BA; Stadler W; Rinker-Schaeffer CW
J Pathol; 2007 Aug; 212(4):386-94. PubMed ID: 17577251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
